/

Società

TR

Non verificato

TRIMTECH Therapeutics

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteSanitàScienza

2 comunicati stampa

Guarda tutti i comunicati

23/06/2026

Salute

Scienza

Biotecnologia

TRIMTECH Therapeutics Brings Total Seed Round to $47M with Additional Investment of $14M to Further Develop TRIMTAC and TRIMGLUE Targeted Protein Degradation Portfolio

Fonte

TRIMTECH Therapeutics

Emittente

1.00

0

05/03/2025

Salute

Sanità

Scienza

Farmaceutica

Biotecnologia

TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases

Fonte

TRIMTECH Therapeutics

Emittente

1.00

0

Seguaci

0

Compatibilità

0